about
In silico mechanistic profiling to probe small molecule binding to sulfotransferasesIntegrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6.Dihydroisocoumarin glucosides from stem bark of Caryocar glabrum.Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.Toward in silico structure-based ADMET prediction in drug discovery.Neutrophil elastase as a target in lung cancer.The Cytochrome P450 3A4 Has Three Major Conformations: New Clues to Drug Recognition by this Promiscuous Enzyme.PatchSearch: A Fast Computational Method for Off-Target Detection.Sampling of conformational ensemble for virtual screening using molecular dynamics simulations and normal mode analysis.PEP-SiteFinder: a tool for the blind identification of peptide binding sites on protein surfaces.JNK contributes to Hif-1alpha regulation in hypoxic neurons.Structural characterization of human elastin derived peptides containing the GXXP sequence.Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD).Peptide Suboptimal Conformation Sampling for the Prediction of Protein-Peptide Interactions.Design, Synthesis, and Use of MMP-2 Inhibitor-Conjugated Quantum Dots in Functional Biochemical Assays.A proposed interaction mechanism between elastin-derived peptides and the elastin/laminin receptor-binding domain.Four Major Channels Detected in the Cytochrome P450 3A4: A Step toward Understanding Its MultispecificitySimultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studiesInhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s)De novo peptide structure prediction: an overviewIn silico characterization of the interaction between LSKL peptide, a LAP-TGF-beta derived peptide, and ADAMTS1Interest of new alkylsulfonylhydrazide-type compound in the treatment of alcohol use disordersMolecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea CatechinsUnexpected effect of cyclodepsipeptides bearing a sulfonylhydrazide moiety towards histone deacetylase activityPatchSearch: a web server for off-target protein identification
P50
Q28536904-C6C18CCF-85D4-470D-BB21-9DC169BE7466Q30378479-5887608C-5B90-44F6-9346-6189C557C966Q34647408-BCF9961D-6842-4C11-B816-A524F45D1EBEQ37458259-84A325F3-3842-4E17-B874-43D9135A3098Q37953143-DE625355-AF22-43F9-9E5E-F580E1300EF1Q37977483-C519B975-6886-4F6B-AD90-415F49A7C7F4Q38689714-4F4FA3A3-3507-4F34-BC04-D1135E9146EEQ38915005-DF8E7CCC-22B0-40CF-BD21-5F719291186EQ38939477-DFCD6DFC-0026-42AB-9DCC-2282A78CB8F8Q42122972-8726569C-9A2A-4B39-9E6B-F10C219EADE4Q42466549-8FE64F14-0D80-4947-97D9-28B4F8157538Q46424157-3F077F4F-DB59-4022-8788-799E97350C9DQ48299622-F7748FEC-6E75-4B54-B21D-1A4E6435D2CAQ51123309-82300993-27B9-4196-9F1F-E5FA50FC3703Q51478986-D6372D52-1E6F-4644-A5DA-7707AC4CDB1EQ51800514-46BF1CB2-E8D2-4E45-A597-FDA44786CE1CQ64105330-0DE6B530-9AF6-480F-8116-D8F68070DC02Q80356772-B6722B9A-49AA-4AF4-A1A9-D2D09EE5CD9EQ82827642-9E4F5F96-32D1-4ADB-A315-F079D1599BABQ86445532-2B139E75-88D9-4B8E-A33D-3B6ED64C961FQ87294585-EBA0DDF3-4014-4CE3-AC5B-CBDE4FC92117Q88527614-5D2FE521-9AC7-4B21-91EA-9FC3C1F338A9Q89860485-2F3A940E-2BE4-4F7C-823A-5C4515B864DFQ91180391-1D4DD705-4C2E-4E84-9DE5-7B99DF98C7E3Q92309930-A054FA7C-41EB-4AC4-B3AE-24E79E80CA59
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gautier Moroy
@ast
Gautier Moroy
@en
Gautier Moroy
@es
Gautier Moroy
@nl
type
label
Gautier Moroy
@ast
Gautier Moroy
@en
Gautier Moroy
@es
Gautier Moroy
@nl
prefLabel
Gautier Moroy
@ast
Gautier Moroy
@en
Gautier Moroy
@es
Gautier Moroy
@nl
P106
P2456
P31
P496
0000-0002-8973-0477